Radiation Oncology

ASTRO 2024

Questions discussed in this category

What are your top takeaways in Head & Neck Cancers from ASTRO 2024?

1 Answer available

What are your top takeaways in Breast Cancer from ASTRO 2024?

4 Answers available

What are your top takeaways in Thoracic Cancers from ASTRO 2024?

1 Answer available

What are your top takeaways in GU Cancers from ASTRO 2024?

6 Answers available

What are your top takeaways in GI Cancers from ASTRO 2024?

4 Answers available

What are your top takeaways in Neuro Oncology from ASTRO 2024?

1 Answer available

What are your top takeaways in Supportive Care from ASTRO 2024?

3 Answers available

How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?

Are you routinely offering a 16-fraction course of hypofractionated PMRT for patients undergoing breast reconstruction versus a traditional 25-fractio...

4 Answers available

As PARTIQoL was a negative study, what is the current role for proton therapy in the management of prostate cancer patients?

The study showed no benefit in terms of cancer control or toxicity. There was a significant finding of worse sexual function, but this was deemed to b...

2 Answers available

Papers discussed in this category

Radiation oncology (London, England), 2015-10-24

Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer.

J Clin Oncol, 2021 Jan 20

Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial.

International journal of radiation oncology, biology, physics, 2024 Sep 01

Point: Rectal Spacer Use is Recommended for All Prostate Cancer Radiation Therapy Fractionation Regimens.

International journal of radiation oncology, biology, physics, 2024 Sep 01

Counterpoint: The Perplexing Prevalence of Hydrogel Spacer Devices: We Simply Don't Need Them.

International journal of radiation oncology, biology, physics, 2024 Sep 26

Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy vs. IMRT for Localized Prostate Cancer.

The Prostate, 2023 Mar 22

Proton therapy for high-risk prostate cancer: Results from the Proton Collaborative Group PCG 001-09 prospective registry trial.

BMJ Open, 2019 Oct 15

Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol.

J Clin Oncol, 2020 Jul 30

Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.

JAMA oncology, 2024 Oct 01

Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction: A Randomized Clinical Trial.

Lancet Oncol., 2019 Jan 30

Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial.

International journal of radiation oncology, biology, physics, 2014-03-01

Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis.

Related Topics in Radiation Oncology